Literature DB >> 11305320

Apoptosis in oncology.

X Q Fan1, Y J Guo.   

Abstract

Apoptosis is a complex process involving a large array of genes and mutation of any of these genes may lead to malignancy formation. Re-acquirement of FasL by tumor cells may enable them to evade the surveillance of immune system and thus contributes to the growth of tumor. Apart from traditional therapies, inducing apoptosis of tumor cell by new methods employing death receptor ligands and making use of Fas counterattack is also being developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305320     DOI: 10.1038/sj.cr.7290060

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  16 in total

1.  Polymorphisms of the FAS and FASL genes and risk of breast cancer.

Authors:  Wenmin Wang; Zhongqiu Zheng; Wenjie Yu; Hui Lin; Binbin Cui; Feilin Cao
Journal:  Oncol Lett       Date:  2011-12-28       Impact factor: 2.967

2.  Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis.

Authors:  Jing Zhu; Lei Lu; Xiang Cheng; Rongkai Xie; Zhengqiong Chen; Youfei Li; Guilan Lin; Jianmei Liu; Ying Yang
Journal:  Tumour Biol       Date:  2014-03-12

3.  Tributyrin inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest.

Authors:  Jun Yan; Yong-Hua Xu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species.

Authors:  Hong-Liang Li; Dan-Dan Chen; Xiao-Hong Li; Hai-Wei Zhang; Yan-Qing Lu; Chun-Ling Ye; Xian-Da Ren
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 5.  Advances in short bowel syndrome: an updated review.

Authors:  Igor Sukhotnik; Arnold G Coran; Alexander Kramer; Eitan Shiloni; Jorge G Mogilner
Journal:  Pediatr Surg Int       Date:  2005-11-03       Impact factor: 1.827

6.  Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.

Authors:  Merve Kulbay; Bruno Johnson; Guillaume Ricaud; Marie-Noëlle Séguin-Grignon; Jacques Bernier
Journal:  Mol Cell Biochem       Date:  2022-04-22       Impact factor: 3.842

7.  Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo.

Authors:  Yun Zeng; Gang Liu; Li-Ming Zhou
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

8.  The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.

Authors:  Yeqiong Xu; Qiwen Deng; Bangshun He; Yuqin Pan; Rui Li; Tianyi Gao; Huiling Sun; Guoqi Song; Shukui Wang; William C Cho
Journal:  Tumour Biol       Date:  2014-06-12

9.  FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.

Authors:  Hongguang Zhao; Wenhu Chen; Peng Du; Aihua Sun; Chenyu Zhuang; Jiali Tong; Lifang Wang
Journal:  Tumour Biol       Date:  2015-01-18

10.  Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects.

Authors:  Xiongjie Yu; Yanli Li; Yuandong Yu; Jinhua Lei; Guoxing Wan; Fengjun Cao
Journal:  Onco Targets Ther       Date:  2016-04-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.